Literature DB >> 14978134

Persistent and selective deficiency of CD4+ T cell immunity to cytomegalovirus in immunocompetent young children.

Wenwei Tu1, Sharon Chen, Margaret Sharp, Corry Dekker, Anne Marie Manganello, Eileen C Tongson, Holden T Maecker, Tyson H Holmes, Zhaoti Wang, George Kemble, Stuart Adler, Ann Arvin, David B Lewis.   

Abstract

Healthy young children who acquire CMV have prolonged viral shedding into the urine and saliva, but whether this is attributable to limitations in viral-specific immune responses has not been explored. In this study, we found that otherwise immunocompetent young children after recent primary CMV infection accumulated markedly fewer CMV-specific CD4(+) T cells that produced IFN-gamma than did adults. These differences in CD4(+) T cell function persisted for more than 1 year after viral acquisition, and did not apply to CMV-specific IFN-gamma production by CD8(+) T cells. The IFN-gamma-producing CD4(+) T cells of children or adults that were reactive with CMV Ags were mainly the CCR7(low) cell subset of memory (CD45R0(high)CD45RA(low)) cells. The decreased IFN-gamma response to CMV in children was selective, because their CCR7(low) memory CD4(+) T cells and those of adults produced similar levels of this cytokine after stimulation with staphylococcal enterotoxin B superantigen. CD4(+) T cells from children also had reduced CMV-specific IL-2 and CD154 (CD40 ligand) expression, suggesting an early blockade in the differentiation of viral-specific CD4(+) T cells. Following CMV acquisition, children, but not adults, persistently shed virus in urine, and this was observable for at least 29 mo postinfection. Thus, CD4(+) T cell-mediated immunity to CMV in humans is generated in an age-dependent manner, and may have a substantial role in controlling renal viral replication and urinary shedding.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14978134     DOI: 10.4049/jimmunol.172.5.3260

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  74 in total

1.  Early CMV viremia is associated with impaired viral control following nonmyeloablative hematopoietic cell transplantation with a total lymphoid irradiation and antithymocyte globulin preparative regimen.

Authors:  Joanna M Schaenman; Sumana Shashidhar; Chanu Rhee; Jonathan Wong; Shelly Navato; Ruby M Wong; Dora Y Ho; Sally Arai; Laura Johnston; Janice M Brown
Journal:  Biol Blood Marrow Transplant       Date:  2010-08-22       Impact factor: 5.742

2.  Early age at time of primary Epstein-Barr virus infection results in poorly controlled viral infection in infants from Western Kenya: clues to the etiology of endemic Burkitt lymphoma.

Authors:  Erwan Piriou; Amolo S Asito; Peter O Sumba; Nancy Fiore; Jaap M Middeldorp; Ann M Moormann; Robert Ploutz-Snyder; Rosemary Rochford
Journal:  J Infect Dis       Date:  2012-02-01       Impact factor: 5.226

3.  Type 1 responses of human Vγ9Vδ2 T cells to influenza A viruses.

Authors:  Gang Qin; Yinping Liu; Jian Zheng; Iris H Y Ng; Zheng Xiang; Kwok-Tai Lam; Huawei Mao; Hong Li; J S Malik Peiris; Yu-Lung Lau; Wenwei Tu
Journal:  J Virol       Date:  2011-07-13       Impact factor: 5.103

4.  Immune Correlates of Protection Against Human Cytomegalovirus Acquisition, Replication, and Disease.

Authors:  Cody S Nelson; Ilona Baraniak; Daniele Lilleri; Matthew B Reeves; Paul D Griffiths; Sallie R Permar
Journal:  J Infect Dis       Date:  2020-03-05       Impact factor: 5.226

5.  Maternal CD4+ T cells protect against severe congenital cytomegalovirus disease in a novel nonhuman primate model of placental cytomegalovirus transmission.

Authors:  Kristy M Bialas; Takayuki Tanaka; Dollnovan Tran; Valerie Varner; Eduardo Cisneros De La Rosa; Flavia Chiuppesi; Felix Wussow; Lisa Kattenhorn; Sheila Macri; Erika L Kunz; Judy A Estroff; Jennifer Kirchherr; Yujuan Yue; Qihua Fan; Michael Lauck; David H O'Connor; Allison H S Hall; Alvarez Xavier; Don J Diamond; Peter A Barry; Amitinder Kaur; Sallie R Permar
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-19       Impact factor: 11.205

6.  Use of specific-pathogen-free (SPF) rhesus macaques to better model oral pediatric cytomegalovirus infection.

Authors:  Myra G dela Pena; Lisa Strelow; Peter A Barry; Kristina Abel
Journal:  J Med Primatol       Date:  2012-06       Impact factor: 0.667

7.  Cytomegalovirus-Specific CD4 T Cells Are Cytolytic and Mediate Vaccine Protection.

Authors:  Shilpi Verma; Daniela Weiskopf; Ankan Gupta; Bryan McDonald; Bjoern Peters; Alessandro Sette; Chris A Benedict
Journal:  J Virol       Date:  2015-10-21       Impact factor: 5.103

8.  Vγ9Vδ2-T lymphocytes have impaired antiviral function in small-for-gestational-age and preterm neonates.

Authors:  Jinrong Li; Hong Li; Huawei Mao; Meixing Yu; Ting Feng; Fan Yang; Yingying Fan; Qiao Lu; Chongyang Shen; Zhongwei Yin; Wenwei Tu; Meng Mao
Journal:  Cell Mol Immunol       Date:  2013-03-25       Impact factor: 11.530

Review 9.  Immune reconstitution after unrelated cord blood transplantation.

Authors:  P Szabolcs; D Niedzwiecki
Journal:  Cytotherapy       Date:  2007       Impact factor: 5.414

10.  Acute cytomegalovirus infection in Kenyan HIV-infected infants.

Authors:  Jennifer A Slyker; Barbara L Lohman-Payne; Grace C John-Stewart; Elizabeth Maleche-Obimbo; Sandra Emery; Barbra Richardson; Tao Dong; Astrid Kn Iversen; Dorothy Mbori-Ngacha; Julie Overbaugh; Vincent C Emery; Sarah L Rowland-Jones
Journal:  AIDS       Date:  2009-10-23       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.